Published in J Med Virol on March 01, 1999
Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J Exp Med (2003) 10.20
Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci U S A (1999) 6.05
Association between hepatitis C virus and very-low-density lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients. J Virol (2006) 2.88
Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I. J Virol (2006) 2.65
Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor. J Virol (2000) 2.50
The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae. J Gen Virol (2010) 2.26
Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor. Virology (2009) 1.72
The ins and outs of hepatitis C virus entry and assembly. Nat Rev Microbiol (2013) 1.69
Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry. J Virol (2002) 1.66
RNA interference and single particle tracking analysis of hepatitis C virus endocytosis. PLoS Pathog (2009) 1.65
Studying hepatitis C virus: making the best of a bad virus. J Virol (2007) 1.62
Analysis of a highly flexible conformational immunogenic domain a in hepatitis C virus E2. J Virol (2005) 1.53
Identification of transferrin receptor 1 as a hepatitis C virus entry factor. Proc Natl Acad Sci U S A (2013) 1.43
Hepatitis C virus host cell entry. Curr Opin Virol (2012) 1.41
MicroRNAs regulate the immunometabolic response to viral infection in the liver. Nat Chem Biol (2015) 1.39
Human monoclonal antibody to hepatitis C virus E1 glycoprotein that blocks virus attachment and viral infectivity. J Virol (2004) 1.37
Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt. Gut (2006) 1.34
Hepatitis C virus proteins. World J Gastroenterol (2007) 1.28
Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: putative CD81 binding region 1 is not involved in CD81 binding. Virol J (2008) 1.21
Basic residues in hypervariable region 1 of hepatitis C virus envelope glycoprotein e2 contribute to virus entry. J Virol (2005) 1.21
Lipids and HCV. Semin Immunopathol (2012) 1.19
Residues in a highly conserved claudin-1 motif are required for hepatitis C virus entry and mediate the formation of cell-cell contacts. J Virol (2009) 1.19
Role of the asialoglycoprotein receptor in binding and entry of hepatitis C virus structural proteins in cultured human hepatocytes. J Virol (2003) 1.18
A novel small molecule inhibitor of hepatitis C virus entry. PLoS Pathog (2010) 1.16
Mouse-specific residues of claudin-1 limit hepatitis C virus genotype 2a infection in a human hepatocyte cell line. J Virol (2009) 1.14
Associations between serum lipids and hepatitis C antiviral treatment efficacy. Hepatology (2010) 1.13
Apolipoprotein epsilon3 allele is associated with persistent hepatitis C virus infection. Gut (2005) 1.11
CD46 is a cellular receptor for bovine viral diarrhea virus. J Virol (2004) 1.11
Potential cellular receptors involved in hepatitis C virus entry into cells. Lipids Health Dis (2005) 1.10
Temporal analysis of hepatitis C virus cell entry with occludin directed blocking antibodies. PLoS Pathog (2013) 1.08
Species-specific regions of occludin required by hepatitis C virus for cell entry. J Virol (2010) 1.07
Hepatitis C virus E1 envelope glycoprotein interacts with apolipoproteins in facilitating entry into hepatocytes. Hepatology (2011) 1.06
Coexpression of hepatitis C virus E1 and E2 chimeric envelope glycoproteins displays separable ligand sensitivity and increases pseudotype infectious titer. J Virol (2004) 1.02
Syndecan-1 serves as the major receptor for attachment of hepatitis C virus to the surfaces of hepatocytes. J Virol (2013) 1.02
Hepatitis C Virus entry: the early steps in the viral replication cycle. Virol J (2009) 1.01
Hepatitis C virus differentially modulates activation of forkhead transcription factors and insulin-induced metabolic gene expression. J Virol (2010) 1.00
Flow cytometric detection of hepatitis C virus antigens in infected peripheral blood leukocytes: binding and entry. World J Gastroenterol (2005) 0.95
The rate of hepatitis C virus infection initiation in vitro is directly related to particle density. Virology (2010) 0.94
Hepatitis C virus evasion mechanisms from neutralizing antibodies. Viruses (2011) 0.93
Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines. Virology (2013) 0.93
Exploitation of lipid components by viral and host proteins for hepatitis C virus infection. Front Microbiol (2012) 0.92
Identification of a hepatic factor capable of supporting hepatitis C virus replication in a nonpermissive cell line. J Virol (2001) 0.92
Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection. Viruses (2015) 0.91
The individual and combined influence of HIV and hepatitis C virus on dyslipidaemia in a high-risk Hispanic population. HIV Med (2009) 0.91
Murine models of hepatitis C: what can we look forward to? Antiviral Res (2014) 0.90
Incorporation of hepatitis C virus E1 and E2 glycoproteins: the keystones on a peculiar virion. Viruses (2014) 0.88
Serum hs-CRP was correlated with treatment response to pegylated interferon and ribavirin combination therapy in chronic hepatitis C patients. Hepatol Int (2010) 0.87
AP-2-associated protein kinase 1 and cyclin G-associated kinase regulate hepatitis C virus entry and are potential drug targets. J Virol (2015) 0.85
Determining the involvement and therapeutic implications of host cellular factors in hepatitis C virus cell-to-cell spread. J Virol (2014) 0.85
How hepatitis C virus invades hepatocytes: the mystery of viral entry. World J Gastroenterol (2014) 0.85
Targeting host lipid synthesis and metabolism to inhibit dengue and hepatitis C viruses. Antiviral Res (2015) 0.84
Hepatitis C virus infection and nonalcoholic steatohepatitis. Gastroenterol Hepatol (N Y) (2012) 0.84
Tight Junctions Go Viral! Viruses (2015) 0.84
The laminin receptor is a cellular attachment receptor for classical Swine Fever virus. J Virol (2015) 0.84
The role of cellular adhesion molecules in virus attachment and entry. Philos Trans R Soc Lond B Biol Sci (2015) 0.83
Role of the low-density lipoprotein receptor in entry of bovine viral diarrhea virus. J Virol (2006) 0.82
Visualizing hepatitis C virus infection in humanized mice. J Immunol Methods (2014) 0.82
Specific interaction of the envelope glycoproteins E1 and E2 with liver heparan sulfate involved in the tissue tropismatic infection by hepatitis C virus. Glycoconj J (2012) 0.82
Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV. Virol J (2011) 0.82
Chronic hepatitis C virus infection and lipoprotein metabolism. World J Gastroenterol (2015) 0.81
Analysis of a conserved RGE/RGD motif in HCV E2 in mediating entry. Virol J (2009) 0.81
Monoclonal antibodies against extracellular domains of claudin-1 block hepatitis C virus infection in a mouse model. J Virol (2015) 0.80
Human liver transplantation as a model to study hepatitis C virus pathogenesis. Liver Transpl (2009) 0.79
HCV entry receptors as potential targets for siRNA-based inhibition of HCV. Genet Vaccines Ther (2011) 0.79
Individualization of chronic hepatitis C treatment according to the host characteristics. World J Gastroenterol (2014) 0.78
HCV Envelope protein 2 sequence comparison of Pakistani isolate and In-silico prediction of conserved epitopes for vaccine development. J Transl Med (2013) 0.78
Role of living donor liver transplantation in the treatment of hepatitis C virus infection. Hepat Mon (2011) 0.77
Lipoprotein receptors and lipid enzymes in hepatitis C virus entry and early steps of infection. Scientifica (Cairo) (2012) 0.77
Polymorphisms near the IFNL3 Gene Associated with HCV RNA Spontaneous Clearance and Hepatocellular Carcinoma Risk. Sci Rep (2015) 0.77
Impact of lipids and lipoproteins on hepatitis C virus infection and virus neutralization. World J Gastroenterol (2014) 0.76
Hepatitis C virus relies on lipoproteins for its life cycle. World J Gastroenterol (2016) 0.76
The missing pieces of the HCV entry puzzle. Future Virol (2015) 0.76
Hepatitis C Virus-Induced Degradation of Cell Death-Inducing DFFA-Like Effector B Leads to Hepatic Lipid Dysregulation. J Virol (2016) 0.76
Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantation. World J Gastroenterol (2005) 0.76
Baseline serum cholesterol is associated with a response to pegylated interferon alfa-2b and ribavirin therapy for chronic hepatitis C genotype 2. Gastroenterol Res Pract (2012) 0.75
Do high lipids help clearance of hepatitis C? Gut (2007) 0.75
Low-density lipoprotein receptor genetic polymorphism in chronic hepatitis C virus Egyptian patients affects treatment response. World J Gastroenterol (2015) 0.75
Receptors for hepatitis C virus. J Virol (2000) 0.75
Oligonucleotide-Lipid Conjugates Forming G-Quadruplex Structures Are Potent and Pangenotypic Hepatitis C Virus Entry Inhibitors In Vitro and Ex Vivo. Antimicrob Agents Chemother (2017) 0.75
Sex-related influence of angiotensin-converting enzyme polymorphisms on fibrosis progression due to recurrent hepatitis C after liver transplantation. J Gastroenterol (2007) 0.75
Overcoming hurdles in hepatitis C virus research: efficient production of infectious virus in cell culture. Int J Biomed Sci (2008) 0.75
Abl Tyrosine Kinase Regulates Hepatitis C Virus Entry. Front Microbiol (2017) 0.75
Association of hepatitis C virus in human sera with beta-lipoprotein. Med Microbiol Immunol (1992) 3.59
Target cell-dependent T cell-mediated lysis of vaccinia virus-infected cells. Eur J Immunol (1975) 3.37
The tyrosine phosphorylated carboxyterminus of the EGF receptor is a binding site for GAP and PLC-gamma. EMBO J (1990) 3.05
Development of a homologous transformation system for the human pathogenic fungus Aspergillus fumigatus based on the pyrG gene encoding orotidine 5'-monophosphate decarboxylase. Curr Genet (1998) 2.69
The GroE chaperonin machine is a major modulator of the CIRCE heat shock regulon of Bacillus subtilis. EMBO J (1997) 2.50
Catatonia as a psychomotor syndrome: a rating scale and extrapyramidal motor symptoms. Mov Disord (1999) 2.46
Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched. Cancer Res (1997) 2.45
Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins. Med Microbiol Immunol (1993) 2.36
Post-translational alterations in transmembrane topology of the hepatitis B virus large envelope protein. EMBO J (1994) 2.35
The role of randomization in clinical studies: myths and beliefs. J Clin Epidemiol (1999) 2.27
TAp73/Delta Np73 influences apoptotic response, chemosensitivity and prognosis in hepatocellular carcinoma. Cell Death Differ (2005) 2.25
Endoscopic ultrasound as an early diagnostic tool for primary sclerosing cholangitis: a prospective pilot study. Endoscopy (2012) 2.01
Precore sequence of hepatitis B virus inducing e antigen and membrane association of the viral core protein. Virology (1986) 2.01
Definition of polymorphisms and haplotypes in the interleukin-12B gene: association with IL-12 production but not with Crohn's disease. Genes Immun (2004) 1.89
Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity (1995) 1.83
Isolation and characterization of a pigmentless-conidium mutant of Aspergillus fumigatus with altered conidial surface and reduced virulence. Infect Immun (1997) 1.82
A multi-site study using high-resolution HLA genotyping by next generation sequencing. Tissue Antigens (2011) 1.81
Time to detection of Mycobacterium tuberculosis in sputum culture correlates with outcome in patients receiving treatment for pulmonary tuberculosis. Chest (1998) 1.79
Mapping a region of the large envelope protein required for hepatitis B virion maturation. J Virol (1994) 1.73
The activation of female sex hormones: alpha-Oestradiol and its di-esters. Biochem J (1938) 1.69
Differentiation of species and strains among filamentous fungi by DNA fingerprinting. Curr Genet (1991) 1.65
Standardized detection of hepatitis B surface antigen: determination of its serum concentration in weight units per volume. Dev Biol Stand (1975) 1.63
Systematic assessment of atypical deletions reveals genotype-phenotype correlation in 22q11.2. J Med Genet (2005) 1.62
Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas. Cancer Res (2001) 1.60
Quantitative detection of hepatitis B virus DNA in two international reference plasma preparations. Eurohep Pathobiology Group. J Clin Microbiol (1999) 1.59
Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase. Leukemia (2007) 1.58
The effect of research on readmission to a psychiatric hospital. Br J Psychiatry (1990) 1.51
The activation of female sex hormones: Oestrone and its esters. The output of activity and efficiency coefficient. Biochem J (1938) 1.49
Value of magnifying chromoendoscopy and narrow band imaging (NBI) in classifying colorectal polyps: a prospective controlled study. Endoscopy (2007) 1.46
Comprehensive genomic analysis of desmoplastic medulloblastomas: identification of novel amplified genes and separate evaluation of the different histological components. J Pathol (2006) 1.45
Screening by specialists to reduce unnecessary test ordering in patients evaluated for tuberculosis. Chest (1998) 1.45
Experimental non-A, non-B hepatitis: four types of cytoplasmic alteration in hepatocytes of infected chimpanzees. Virchows Arch B Cell Pathol Incl Mol Pathol (1980) 1.43
The relevance of circulating epithelial tumor cells (CETC) for therapy monitoring during neoadjuvant (primary systemic) chemotherapy in breast cancer. Ann Oncol (2007) 1.42
Cutoff levels of immunoglobulin M antibody against viral core antigen for differentiation of acute, chronic, and past hepatitis B virus infections. J Clin Microbiol (1986) 1.41
Cardiac myocytes of hearts from patients with end-stage dilated cardiomyopathy do not contain Borrelia burgdorferi DNA. Am Heart J (1999) 1.41
Dose-time dependency of hyperbaric hyperoxia-induced DNA strand breaks in human immune cells visualized with the comet assay. Undersea Hyperb Med (2014) 1.40
[Off-label=off-legal=illegal?]. Pneumologie (2005) 1.39
[Randomization in clinical studies. Empirically founded or only a dogma?]. Internist (Berl) (1997) 1.38
Nondifferentiation between Lyme disease spirochetes from vector ticks and human cerebrospinal fluid. J Infect Dis (1995) 1.33
Risk factors for rifampin-monoresistant tuberculosis: A case-control study. Am J Respir Crit Care Med (1999) 1.33
The failing human heart is unable to use the Frank-Starling mechanism. Circ Res (1994) 1.31
Comparison of the lysogeny modules from the temperate Streptococcus thermophilus bacteriophages TP-J34 and Sfi21: implications for the modular theory of phage evolution. Virology (1998) 1.31
Hepatitis B virus core gene mutations which block nucleocapsid envelopment. J Virol (2000) 1.31
Extracellular ATP and TNF-alpha synergize in the activation and maturation of human dendritic cells. J Immunol (2000) 1.31
Possible role of acetaldehyde in ethanol-related rectal cocarcinogenesis in the rat. Gastroenterology (1990) 1.30
Nucleotide sequence of the ospAB operon of a Borrelia burgdorferi strain expressing OspA but not OspB. Infect Immun (1992) 1.29
Characterization of the aes gene of Escherichia coli encoding an enzyme with esterase activity. J Bacteriol (1997) 1.23
Organic molecular soft ferromagnetism in a fullerene c60. Science (1991) 1.23
Binding of human lipoproteins (low, very low, high density lipoproteins) to recombinant envelope proteins of hepatitis C virus. Med Microbiol Immunol (2000) 1.22
Failure of potassium siphoning by Müller cells: a new hypothesis of perfluorocarbon liquid-induced retinopathy. Invest Ophthalmol Vis Sci (2000) 1.22
Complementary and alternative therapeutic approaches in patients with early breast cancer: a systematic review. Breast Cancer Res Treat (2006) 1.21
Identification of a binding site in the hepatitis B virus RNA pregenome for the viral Pol gene product. Virology (1991) 1.21
Different pattern of elution of poliovirus strains from DEAE-cellulose and aluminium hydroxide gel. Arch Gesamte Virusforsch (1965) 1.21
Modular structure of the trigger factor required for high activity in protein folding. J Mol Biol (1997) 1.21
Isolation of the gene for the beta subunit of RNA polymerase from rifampicin-resistant Mycobacterium tuberculosis and identification of new mutations. Am J Respir Cell Mol Biol (1994) 1.20
Slit-lamp-adapted optical coherence tomography of the anterior segment. Graefes Arch Clin Exp Ophthalmol (2000) 1.19
Crystallographic analysis of anti-p24 (HIV-1) monoclonal antibody cross-reactivity and polyspecificity. Cell (1997) 1.18
Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines. Cancer Res (2001) 1.17
Pets and vermin are associated with high endotoxin levels in house dust. Clin Exp Allergy (2001) 1.16
Psychological distress and depression in urbanising elderly black persons. S Afr Med J (1991) 1.16
The significance of Mycobacterium avium complex cultivation in the sputum of patients with pulmonary tuberculosis. Chest (1997) 1.16
Immunosuppressive treatment of chronic periaortitis: a retrospective study of 20 patients with chronic periaortitis and a review of the literature. Ann Rheum Dis (2005) 1.15
Molecular characterization of the Bacillus stearothermophilus PV72 S-layer gene sbsB induced by oxidative stress. J Bacteriol (1997) 1.15
ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy. Diabetologia (2003) 1.14
Epidemiology and clinical manifestations of Lyme borreliosis in childhood. A prospective multicentre study with special regard to neuroborreliosis. Acta Paediatr Suppl (1993) 1.13
Screening for respiratory syncytial virus and assignment to a cohort at admission to reduce nosocomial transmission. J Pediatr (1990) 1.12
Dynamic association of trigger factor with protein substrates. J Mol Biol (2001) 1.11
Titin, myosin light chains and C-protein in the developing and failing human heart. J Mol Cell Cardiol (1994) 1.10
Assay of hepatitis B virus genome titers in sera of infected subjects. Eur J Clin Microbiol (1986) 1.09
Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats. J Am Soc Nephrol (2000) 1.09
Ongoing tuberculosis transmission to children in Greenland. Eur Respir J (2010) 1.09
Processing of the Borna disease virus glycoprotein gp94 by the subtilisin-like endoprotease furin. J Virol (1998) 1.08
Corneal optical coherence tomography before and immediately after excimer laser photorefractive keratectomy. Am J Ophthalmol (2000) 1.08
Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma. J Pathol (2008) 1.07
Effects of the mu-opioid receptor antagonist GSK1521498 on hedonic and consummatory eating behaviour: a proof of mechanism study in binge-eating obese subjects. Mol Psychiatry (2012) 1.06
The interleukin-6 (IL6)-174 G/C promoter genotype is associated with the presence of septic shock and the ex vivo secretion of IL6. Int J Immunogenet (2007) 1.06
Beta(1-->3)-glucan in house dust of German homes: housing characteristics, occupant behavior, and relations with endotoxins, allergens, and molds. Environ Health Perspect (2001) 1.05
Predictors of high endotoxin concentrations in the settled dust of German homes. Indoor Air (2002) 1.05
The adhesive binding site of cadherins revisited. Biophys Chem (1999) 1.05
Etiology of the acrodermatitis chronica atrophicans lesion in Lyme disease. J Infect Dis (1996) 1.05
The anterior and posterior 'stomach' regions of larval Aedes aegypti midgut: regional specialization of ion transport and stimulation by 5-hydroxytryptamine. J Exp Biol (1999) 1.05
Liquid-phase hybridization and capture of hepatitis B virus DNA with magnetic beads and fluorescence detection of PCR product. J Virol Methods (1994) 1.05
Biventricular thrombi in dilated cardiomyopathy: massive simultaneous pulmonary and systemic embolisation. Eur Heart J (1994) 1.05
Letter: Flower vases and pathogens. Lancet (1974) 1.04
Routine use of transrectal ultrasound in rectal carcinoma: results of a prospective multicenter study. Endoscopy (2002) 1.04
Characterization of unusual escape variants of hepatitis B virus isolated from a hepatitis B surface antigen-negative subject. J Virol (1998) 1.04
Characterization of the endogenous protein kinase activity of the hepatitis B virus. Arch Virol Suppl (1993) 1.03
Bacterial infections in human immunodeficiency virus-infected children. Pediatr Infect Dis J (1988) 1.03
The third epidemic--multidrug-resistant tuberculosis. Chest (1994) 1.02
Continuous 20-24 hr Esophageal pH-monitoring in infancy. J Pediatr Surg (1981) 1.02
Expression of major histocompatibility class II antigens on polymorphonuclear neutrophils in patients with Wegener's granulomatosis. Kidney Int (1999) 1.00
Increasing incidence of Mycobacterium xenopi at Bellevue hospital: An emerging pathogen or a product of improved laboratory methods? Chest (2000) 0.99
Primary and secondary structure specificity of the cleavage of 'single-stranded' DNA by endonuclease Hinf I. Nucleic Acids Res (1982) 0.99
Tracer test with As(V) under variable redox conditions controlling arsenic transport in the presence of elevated ferrous iron concentrations. J Contam Hydrol (2006) 0.99
Mapping of the spinal muscular atrophy (SMA) gene to a 750-kb interval flanked by two new microsatellites. Eur J Hum Genet (1995) 0.98
Emergency operation in carcinomas of the left colon: value of Hartmann's procedure. Tech Coloproctol (2004) 0.98
Neuroprotection by oxygen in acute transient focal cerebral ischemia is dose dependent and shows superiority of hyperbaric oxygenation. Cerebrovasc Dis (2008) 0.98